Latest Kaiser Health News Stories
Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
California has listed the active ingredient in Monsanto’s Roundup as a cancer-causing agent and will require warning labels on it starting next year. The company says that the listing is unjustified and that science is on its side.
Advertising for hospitals, unlike pharmaceutical companies, doesn’t have to be backed up by data or facts. Cheerful messages of hope can feel like a slap in the face to a dying patient.
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
A draft recommendation from the U.S. Preventive Services Task Force says women between ages 30 and 65 should get a Pap test every three years or an HPV screening every five years, but they don’t need to do both.
Study suggests that many small tumors are sleepy, not deadly.
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
As we get older, it helps to tickle the noggin with trivia. Here’s a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.